RFK won’t get what he wants, Trump loves pharma (see his previous term) and only brought the guy onboard for a few extra votes. M&A is also set to surge under a Trump presidency, with Trump already announcing intentions to sack the current FTC boss and making business combinations significantly easier. This is obviously incredibly beneficial for CU6, a company that would very likely be acquired next year regardless. It’ll be a volatile next four years, but IMO a very good four years to be a business (especially in Pharma)
Looks, Trump’s already making the guy go against his values:
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M | |||
| Open | High | Low | Value | Volume |
| $2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6820 | $2.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.52 | 3500 | 1 |
View Market Depth
| Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |